The Broadcom Trap: When a Blowout Quarter Isn't Enough

# The Broadcom Trap: When a Blowout Quarter Isn't Enough

Let me tell you a story that will make your blood run cold, because it's the story of Broadcom right now.

On September 2nd, Broadcom reported Q3 earnings that would have launched most stocks to the moon. Revenue of $29.59 billion, up 85.5% year over year. AI semiconductor revenue surging roughly 221% to $16.7 billion. EPS of $3.32 against expectations near $3.16. Management steering guidance up to ~$34.8 billion for Q4, with ~$21.7 billion in AI semis, and throwing out a $115 billion AI revenue target for FY2027 and $230 billion for FY2028.

And the stock? It fell.

This is the trap, and it's a brutal one.

The Pattern That Bites

Read that again. The numbers were magnificent, and the shares dropped. This isn't the first time. In June, Broadcom fell roughly 12 to 18 percent in a single session after a softer forward AI guide. The market didn't care about the quarter. It cared about the horizon.

Here's the uncomfortable truth about AVGO in September 2026: it's trading in a "merely excellent" regime. When the stock runs hot and prices in perfection, excellence isn't enough. You have to be transcendent, and you have to show me the horizon is even bigger than I feared. Otherwise, the sell-the-news reflex kicks in and nobody blinks.

Right now, the stock sits near $357, roughly flat year-to-date and about 25 percent below its 52-week high of ~$495. It's below its 20-day, 50-day, and 200-day moving averages—a bearish stack with no reversal in sight. RSI at 44, neutral-to-weak, not oversold. Nobody's calling a bottom.

But Wait — The Business Is a Monster

Don't mistake a de-rating for a dying franchise. The fundamentals here are genuinely best-in-class, and I'll say so plainly.

Operating margins near 54 percent. A ~$55 billion free cash flow run-rate. ROE of 44 percent. A balance sheet that has materially deleveraged, with debt down to $59.4 billion and cash up to $24 billion. Broadcom holds an estimated 70 percent of the custom AI ASIC market and owns the design-win franchise with Google, Meta, Anthropic, and OpenAI. We're talking roughly $350 billion in reportedly locked shipments for FY2027 through FY2028. An OpenAI accelerator built in nine months. Multi-gigawatt commitments stretching out years.

This is one of the highest-quality compounding machines on the planet. I'm not going to pretend otherwise.

So Why the Punt?

Because the market is now pricing a different story than the one in the earnings call, and the bears have real ammunition.

First, the margins. Q3 gross margin contracted to roughly 75 percent, and Q4 is guided down toward 73 percent, versus about 78 percent a year prior. Why? Because lower-margin, memory-intensive custom accelerators are growing faster than the higher-margin software business. Revenue is beautiful. The mix is doing something to the profitability that attentive buyers notice.

Second, the customers who pay the bills are shopping around. Google signed a custom-chip deal with Marvell. Google is qualifying additional suppliers. Meta is preparing to build its own AI chips to reduce Nvidia reliance. Broadcom's moat is real, but the moat is being widened by the very clients that fund it. Second-sourcing is a slow knife.

Third, the valuation. Even after the drawdown, this trades near 18 to 20x forward earnings. Yes, that's a discount to Nvidia's ~45x. But a discount only helps if the growth sustains. If any hyperscaler pauses capex, if the China review of Broadcom equipment turns sour, if memory supply constricts — the multiple compresses fast on a high-beta, 1.48 name.

And fourth, the guidance sensitivity. Hock Tan's incentives are reportedly tied to a $60 billion FY2027 AI-revenue milestone, with forfeiture risk. That's a real reason to wonder whether the forward guide is a candid read on the business or a calculated move to hit a number. I flag it not as an accusation but as a reason to read the tape, not the press release.

My Take

Here's where I land, and I'll be straight with you.

Broadcom is a quality name in a de-rating phase, and those two facts are in tension. The business is elite. The street still believes in it — the average price target sits near $518 to $526, with Morgan Stanley at $505 and a range running from roughly $216 to $715. That range alone tells you this is one of the most polarizing stocks on the board.

But "believe in the long term" is an easy thing to say and a hard thing to execute at the right price. The technicals are weak. The momentum is against you. The stock has shown you, twice now, that a great quarter means nothing if the horizon doesn't excite.

So what's the play? I would not chase this. I'd accumulate on strength, or on a meaningful pull toward the $325 to $330 support zone and then the $290 52-week low — not on a bounce off the 20-day average into fading resistance at $360 to $370. Buy the ugly, not the hopeful.

The December 10 earnings print (after the U.S. close) will be the next real test, and given the pattern, expect the market to punish a mere beat and reward only a guide that redefines the ceiling.

One thing I'll leave you with: the market doesn't pay you for being right about the business. It pays you for being right about the price and the timing. Broadcom's business is a five-bagger's genome. Its stock, right now, is a test of patience, discipline, and the stomach to buy when the tape looks weak and the fundamentals look strong.

Buy the dip if you have the nerve. But know exactly which side of the trade you're on.